Increasingly rigorous standards of transparency are required when sharing scientific and clinical information, and pharmaceutical companies are responding by segmenting their commercial promotion, (which educates customers on the prescription, supply, sale or use of medicines and vaccines) and non-promotional scientific dialogue and activities, such as advisory boards, publications, scientific congress activities, and other engagement with key stakeholders.

As an agency, we need to be able to demonstrate a clear separation between these two areas of support within our organisation. Our business model makes it very easy to ensure that there is no cross over between teams working on different projects. We also have a second company, Livewire Science, which formalises that distinction. All scientific meetings and writing projects categorised as non-promotional are handled by Livewire Science.